• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

immunology

Womens Health The Top Line
Podcast

Angus on Angus: A Fierce oncology discussion

Two journalists, one name and a candid conversation—Angus Liu and Angus Chen talk cancer reporting, racial identity and being mistaken for each other.
Ayla Ellison , Angus Liu Apr 25, 2025 9:41am
Rift split divide division argument stalemate disagreement

Regeneron sues Sanofi over Dupixent commercialization discord

Feb 6, 2025 3:56pm
3d rendering of a semi-opened steel safe box with many paper dollar banknotes flying out of it

AbbVie's Skyrizi rockets to top of TV drug ad spenders' list

Nov 7, 2024 9:13am
sold

Nektar extends cash runway with $90M manufacturing plant sale

Nov 4, 2024 1:16pm
eczema atopic dermatitis Black African American patient skin of color

J&J's Tremya, Lilly's Ebglyss score in new patient groups

Oct 25, 2024 11:00am
Vtama

Organon pays up to $1.2B to acquire Dermavant and its drug Vtama

Sep 18, 2024 10:09am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings